Mutagenic and cytotoxic effect of planifolin: A naphthopyranone dimer isolated from Paepalanthus planifolius

Toxicology in Vitro

Volumn 20, Issue 5, 2006, Pages 664-668

  Varanda, Eliana Aparecida ^a   Varella, Soraya Duarte ^a   Rampazo, Raquel Aparecida ^a   Kitagawa, Rodrigo Rezende ^a   Raddi, Maria Stella Gonçalves ^a   Vilegas, Wagner ^a   dos Santos, Lourdes Campaner ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Mutagenicity; Planifolin; Salmonella typhimurium

Indexed keywords

DIMER; NAPHTHOPYRANONE; NEUTRAL RED; PLANIFOLIN; PYRAN DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; AMES TEST; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DNA SEQUENCE; DOSE RESPONSE; DRUG SCREENING; DRUG STRUCTURE; GENE DELETION; GENE MUTATION; METABOLIC ACTIVATION; MOUSE; MUTAGENICITY; NONHUMAN; PAEPALANTHUS PLANIFOLIUS; PLANT; SALMONELLA TYPHIMURIUM;

ANIMALS; CELL LINE; DIMERIZATION; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; MICE; MUTAGENS; NAPHTHOLS; PYRONES;

PAEPALANTHUS; SALMONELLA TYPHIMURIUM;

EID: 33745442477     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2005.09.010     Document Type: Article

References (26)

1. Bae E.A., Han M.J., Choo M.K., Park S.Y., and Kim D.H. Metabolism of 20(S)- and 20(R)-ginsenoside R-g3 by human intestinal bacteria and its relation to in vitro biological activities. Biological Pharmaceutical Bulletin 25 (2002) 58-63
2. Barile F.A. Introduction to in vitro cytotoxicology: mechanisms and methods (1994), CRC Press, Inc., Boca Raton 222p
3. Bennet W.M., and Porter G.A. Nephrotoxicity of common drugs used by urologists. Urologic Clinics of North America 17 (1990) 145-154
4. Bernstein L., Kaldor J., Mccann J., and Pike M.C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutation Research 97 (1982) 267-281
5. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicology Letters 24 (1985) 119-124
6. Devienne K.F., Raddi M.S.G., Varanda E.A., and Vilegas W. In vitro cytotoxic of some natural and semi-synthetic isocoumarins from Paepalanthus bromelioides. Zeitschrift-fur-Naturforschung 57c (2002) 85-88
7. Einhorn L. Combination chemotherapy in disseminated testicular cancer. Cancer Treatment Reports 63 (1979) 659-662
8. Ferguson L.R., and Denny W.A. Anticancer drugs: and underestimated risk or an underutilized resource in mutagenesis?. Mutation Research 331 (1995) 1-26
9. Frisch, M.J., Trucks, G.W., Schlegel, H.B., Gill, P.M.W., Johnsonm B.G., Robb, M.A., Cheesema, J.R., Keith, T.A., Peterson, G.A., Montgomery, J.A., Raghavachari, K., Al-Lahan, M.A., Zakrzewski, V.G., Ortiz, J.V., Foresman, J.B., Cioslowski, J., Stejanov, B.B., Nanayakkara, A., Challacombe, M., Peng, C.Y., Ayaba, P.Y., Chen, W., Wong, M.W., Andres, J.L., Replogle, E.S., Gomperts, R., Martin, R.L., Fox, D.J., Binkley, J.S., Defrees, D.J., Baker, J., Stemart, J.P., Head-Gordon, J.S., Gonzalez, C., Pople, J.A., 1995. Gaussian 94, Inc. Pittsburg PA.
10. Hamburger M., and Hostetmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry 30 12 (1991) 3864-3884
11. Hill R.A. Naturaly occurring isocoumarins. Fortschritte der Chemie Organischer Naturstoffe 49 (1986) 1-78
12. Lapponi, J.C., 1997. Estatistica: Usando Excel 5 e 7. São Paulo, Lapponi, 1997, 420p.
13. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Research 113 (1983) 173-225
14. Mortelmans K., and Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutation Research 455 (2000) 29-60
15. Pauwels O., Kiss R., Pasteels J.L., and Atassi G. Characterization of alkylating versus intercalating anticancer drug-induced effects on cell survival, cell cycle kinetic and morphonuclear pattern of three neoplastic cells lines growing in vitro. Pharmaceutical Research 12 (1995) 1011-1018
16. Santos L.C., Piacente S., Pizza C., Albert K., Dachtler M., and Vilegas W. Planifolin, a new naphthopyranone dimer and flavonoids from Paepalanthus planifolius. Journal of Natural Products 64 (2001) 122-124
17. Simões, C.M.O., Sckenkel, E.P., Gosman, G., Mello, J.C.P., Mentz, L.A., Petrovick, P.R., 1999. Farmacognosia: da planta ao medicamento. Universidade/UFRGS/UFSC, Porto Alegre/Florianópolis, 1999, p. 821.
18. Tao Z.F., Fan M.C., and Qian X.H. Synthesis of novel DNA-intercalating naphthopyrone derivatives with improved water solubility and photophysical properties. Monatshefte fur Chemie 130 9 (1999) 1109-1116
19. Tavares D.C., Varanda E.A., Andrade F.P.D., Vilegas W., and Takahashi C.S. Evaluation of the genotoxic potencial of the isocoumarin paepalantine in vivo and in vitro mammalian system. Journal of Ethnopharmacology 68 (1999) 115-120
20. Varanda E.A., Raddi M.S.G., Dias F.L., Araujo M.C.S., Gibran S.C.A., Takahashi C.S., and Vilegas W. Mutagenic and cytotoxic activity of an isocoumarin (Paepalantine) isolated from Paepalnthus vellozioides. Teratogenesis Carcinogenesis and Mutagenesis 17 (1997) 85-95
21. Varella S.D., Pozzeti G.L., Vilegas W., and Varanda E.A. Mutagenic activity in garbage from a aluminum products factory in Salmonella/microssome assay. Toxicology in Vitro 18 (2004) 895-900
22. Weisburger J.H., Hara Y., Solan L., Luo F.Q., Pittman B., and Zang E. Tea polyphenols as inhibitors of mutagenicity of major classes of carcinogens. Mutation Research 371 (1996) 57-63
23. Wells G., Berry J.M., Bradshaw T.D., Burger A.M., Seaton A., Wang B., Westwell A.D., and Stevens M.F. 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines. Journal of Medicinal Chemistry 46 (2003) 532-541
24. Wilsonm W.D., and Jones R.L. In: Whittingham M.S., and Jacobson A.J. (Eds). Intercalation Chemistry (1982), Academic Press, New York (Chapter 14)
25. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual Review of Nutrition 21 (2001) 381-406
26. Zeiger E. Identification of rodent carcinogens and non-carcinogens using genetic toxicity tests: premises, promises, and performance. Regulatory Toxicology and Pharmacology 28 (1998) 85-95